Radcivir has been officially approved by the US FDA, and the who said last week that it had little effect

category:Hot
 Radcivir has been officially approved by the US FDA, and the who said last week that it had little effect


However, novel coronavirus pneumonia is not a serious disease. But it is worth noting that only a week ago, the who claimed that drugs including Reed, Wei and so on had little effect on improving the mortality of hospitalized patients with new crown pneumonia.

(function(){( window.slotbydup=window .slotbydup||[]).push({id:u5811557,container:ssp_ 5811557, async:true Novel coronavirus pneumonia, and the results of the unity test were released in October 15th. The results of the unity test were released in October 15th. The results showed that Reed, Wei, hydroxychloroquine, ritonavir / ritonavir and interferon treatment had little effect on the improvement of the mortality or hospitalization duration of the new crown pneumonia inpatients. The study involved more than 30 countries, including the impact of these drugs and therapies on overall mortality, respiratory equipment use and length of stay. However, novel coronavirus pneumonia should be tested by different tests to verify whether other drugs can be used in patients in the community or for preventing new crown pneumonia. Who director general Tan Desai novel coronavirus pneumonia said later that the results of the unity trial interim results showed that Reed, hydroxychloroquine, r-cv, ritonavir and interferon therapy had little effect in preventing the death of new crown pneumonia patients or shortening hospital stays. The United trial will evaluate other therapies, including monoclonal antibodies and new antiviral drugs. For novel coronavirus pneumonia patients, dexamethasone is the only effective drug. Source: editor in charge of daily economic news: Qin bailing_ NB17208

According to CCTV novel coronavirus pneumonia, Reed released the results of the unity test in October 15th. The results showed that the treatment of 28 months of death, hospitalization and hospitalization of new crown pneumonia patients was almost unaffected by the results of the unity test. The study involved more than 30 countries, including the impact of these drugs and therapies on overall mortality, respiratory equipment use and length of stay. However, novel coronavirus pneumonia should be tested by different tests to verify whether other drugs can be used in patients in the community or for preventing new crown pneumonia.

Who director general Tan Desai novel coronavirus pneumonia said later that the results of the unity trial interim results showed that Reed, hydroxychloroquine, r-cv, ritonavir and interferon therapy had little effect in preventing the death of new crown pneumonia patients or shortening hospital stays. The United trial will evaluate other therapies, including monoclonal antibodies and new antiviral drugs. For novel coronavirus pneumonia patients, dexamethasone is the only effective drug.